May 2005

Respiratory Medicine

Brendan C. McKiernan, DVM, DACVIM

Wheat Ridge Veterinary Specialists, Denver, Colorado



Respiratory Disease in Small Animals




RESPIRATORY PHYSIOLOGY

The main function of the respiratory system is obviously gas exchange, yet this system also participates in thermoregulation, the metabolism of endogenous and exogenous chemicals and mediators, and protection of the animal against inhaled substances. Oxygen is brought from the ambient air to the alveoli where it diffuses across the capillary membrane, into the blood and then is distributed to the tissues throughout the body as carbon dioxide moves in the opposite direction. The delivery of O2 into, and the transport of CO2 out of, the body varies with the animal's metabolism but it must be performed with minimal energy cost to the animal. The energy expended to breathe is typically referred to as the work of breathing (WB).

Large increases in O2 demands in the strenuously exercising animal are met by coordinated increases in ventilation, pulmonary blood flow, and hematocrit (through splenic contraction). The protection against inhaled particulates and gases is provided by a variety of pulmonary defense mechanisms. Changes in the function of these mechanisms can be caused by environmental as well as microbiologic agents and may lead to respiratory disease, which reduces the efficiency of gas exchanges and eventually the animal's performance. The owner usually consults a veterinarian because of changes in their animal's performance or behavior (typically the ability to exercise has decreased, the animal is showing signs of respiratory distress at rest, is making an unusual sound breathing or it is coughing/sneezing excessively).

PULMONARY DEFENSE MECHANISMS: The skin, gastrointestinal tract and the respiratory tract represent the major defensive barriers between the outside world and the body. Both inappropriate management and/or therapeutics can adversely affect normal pulmonary defenses. The gas exchange surface of the lung is a delicate and very extensive membrane that potentially can be damaged by inhaled substances. A resting adult 20kg dog inhales approximately 6,500 liters of air every day. If the dog lives in a rural environment, the air likely contains relatively little in the way of pollutants (particulates or gases). On the other hand, if the dog lives in the city, the air may be quite contaminated. Furthermore, excessive dusts and aerosols in the animal's environment may irritate/damage the respiratory tract - potential exposure to these agents should be discussed with owners where indicated.

PULMONARY DEFENSES: The following is a summary of host defense mechanisms (this brief discussion excludes the specific or immune mechanisms). I believe it is important that we consider how our diagnostics and even therapeutics might impact these defenses.
  1. Upper airways (Figure 1) - the nasal turbinates/air passage-ways.
    In the nasal cavity, the epithelial surface over the turbinates is extensive, serving to warm and humidify air, as well as filter large particles from the incoming air stream. With nasal breathing, warming and humidification of inspired air is essentially complete before air reaches the lower airways.

  2. Protective reflexes - The particular response (the reflex) that is elicited depends less upon the type, strength, intensity and duration of the stimulus applied to the irritant receptors, but rather to their location within the respiratory tract. Receptors may be stimulated by chemical, inflammatory and/or mechanical stimuli. Mechanical deformation may result either from material on the epithelial surface or be secondary to airway narrowing due to bronchoconstriction or external compression. Coughing, which is part of the clearance mechanism of the respiratory tract, is initiated by stimulation of subepithelial irritant receptors that are most numerous near the carina and in the larger bronchi.

    • Sneeze - irritation to the anterior portions of the nasal cavity
    • Reverse sneeze - described decades ago by physiologists, their "aspiration reflex", this is elicited by irritation to the dorsal nasopharyngeal mucosa
    • Cough - coordination of a deep inspiration, followed by a forceful expiration against a closed glottis and finally opening of that glottis to explosively expel air and luminal debris.
    • Airway narrowing - functions to attempt to limit the penetration of irritants deeper into the respiratory tract; includes laryngospasm & bronchospasm.
  3. Mucociliary tree - Cilia beat in a coordinated motion to propel secretions out of the respiratory tract. Primary ciliary dyskenesia (PCD) is a congenital defect in cilial ultrastructure that usually results in secretion retention and chronic rhinitis and bronchitis.
    • Mucous layers - The epithelial cells of the respiratory tract are covered by a periciliary fluid of low viscosity (the sol layer) in which the cilia beat in a coordinated fashion. The gel layer, which may be continuous or in plaques, consists of viscous mucus that protects the sol layer from desiccation and also entraps inhaled particles. The presence of immunoglobulins (e.g. sIgA), complement, opsonins, and lysozyme in respiratory tract secretions assists in the killing/removal of viable particulates such as bacteria.
    • Cilia - beat in nose & trachea is towards the mouth
    • Tracheal mucus transport rates (TMTR) - in the normal individuals are approximately 20 mm/min in the trachea; TMTR decreases to between 2-5 mm/min in chronic bronchitis.
    Mucus secretion and ciliary activity are controlled under autonomic regulation. Stimulation of sympathetic nerves also causes secretion, alpha-receptors apparently being responsible for serous secretion and beta-receptors for mucin secretion. Vagal stimulation, e.g., following inhalation of an irritant substance increases mucus secretion by submucosal glands. Beta-adrenergic stimulation may increase mucociliary clearance. Some inflammatory mediators, particularly the lipoxygenase products of arachidonic acid metabolism (leukotrienes), are potent mucus secretagogues (caution, there are species differences). In the presence of chronic airway irritation (e.g. by dusts or chronic inflammation), submucosal glands hypertrophy and produce increased quantities of mucus, which may be difficult to move via the mucociliary system. I believe secretions like this are a common finding in some of the chronic nasal and lower airway cases that I encounter. Chronic irritation may also lead to goblet cell hyperplasia in peripheral airways so that mucus is secreted into bronchioles poorly equipped for mucus removal. The overall effect is one that can lead to mucus obstruction of peripheral airways and ventilation to perfusion (V/Q) inequalities, as well as the obvious presenting complaints of coughing and nasal discharge.

  4. Bronchus associated lymphatic tissue (BALT) - located in the epithelium of the respiratory tract, analogous to the Pyer's patches of the intestinal tract; very important in Agn processing. The best grossly visible example of BALT is in the clinical condition of follicular pharyngitis.

  5. Pulmonary macrophage (MO) - Particles deposited on the alveolar surface are cleared by phagocytic alveolar macrophages. These cells normally constitute approximately 70-85 per cent of the cells in fluids washed from the lung periphery, i.e. in a bronchoalveolar lavage.
Table 1 - Correlation between structure and function(s).

ANATOMICAL STRUCTURE PHYSIOLOGICAL FUNCTION
Nose, turbinates Primary point for filtering, warming, humidifying of inspired air. Olfaction (including appetite)
Paranasal sinuses Function unknown
Nasopharynx Air conduction, antigen processing
Larynx Phonation, airway protection, entry point to lower airways, major point of airway resistance
Trachea/bronchi Air conduction, primary cough receptor sites, continued processing (warming, filtering, humidifying) of inspired air
Alveoli/capillaries Gas exchange, lung metabolic functions, filtration of blood


Alveolar macrophages form the first line of defense against bacteria and particulates that reach the lung periphery. When large numbers of particulates are inhaled, the macrophage is assisted by other phagocytic cells that enter the alveolus from the blood under the influence of chemotactic stimuli. Polymorphonuclear leukocytes (PMNs) migrate into the lungs more quickly and in larger numbers than monocytes. Phagocytic cells break down particulates by means of toxic O2 radicals and proteolytic enzymes, both of which may leak from the cells and damage the lung tissue. Protease inhibitors such as alpha-1 antitrypsin, and antioxidants such as glutathione peroxidase and superoxide dismutase (SOD) protect the lung from its own defense mechanisms (i.e. help prevent autodigestion). Once phagocytized, particles may be digested by the macrophage or transported out of the lung (e.g up the mucociliary ladder). Suppression of alveolar macrophage function is probably important in the pathogenesis of animal respiratory disease. Macrophages have adapted to the high O2 levels within the alveolus, and their phagocytic ability may be depressed by hypoxia. Corticosteroids suppress the bacterial-killing ability of macrophages and may for example be the cause of the impaired function described after the transportation of animals. Viral infections are another common cause of macrophage function suppression.

PULMONARY PHYSIOLOGY: Clinical signs of respiratory disease (what an owner complains about, what you detect on examination) represent the animal's expression of the functional changes that have resulted secondary to the particular disease. Table 1 summarizes the normal physiological function of the various anatomical portions of the respiratory system. Dys-function at one of these sites would lead directly to many of the presenting signs we commonly recognize in our patients, a simple example would be a coughing after eating/drinking or a change in an animal's voice pointing us to laryngeal disease and the need for a more thorough laryngeal evaluation.

Most organs have considerable reserve before signs become apparent, and this is also true in the lung, where there must be considerable obstruction of small airways or flooding of alveoli before clinical signs are apparent. As there are few quantitative pulmonary function tests in veterinary medicine, the critical (objective) evaluation of respiratory disease may be difficult (more on this later when diagnostics are discussed). Understanding normal physiology will help recognize these functional changes and the pathology that might have caused them. Four classical components of respiratory physiology have been discussed.
  1. Ventilation - Ventilation is simply the movement of air into and out of the lungs. Ventilation is usually "set" at a sufficient level to supply O2 and remove the CO2 produced by the tissues (and sensed by central and peripheral chemoreceptors). In order to do this, ventilation must increase whenever metabolic activity increases, as for example, during exercise. Approximately 33% of ventilation goes to dead space ventilation. Measuring arterial PaCO2 levels can objectively assess the actual adequacy of ventilation.

    Observing an animal breathe at rest is a very important diagnostic skill (observe from a distance, not after he is excited and on an exam table). Inhalation is normally an active process, occurring as the result of contraction of the diaphragm and to a lesser degree the external intercostal muscles. During exercise, or when there is increased respiratory drive, the "accessory muscles" of respiration may be used. These accessory muscles of respiration are located in the upper airway, where they dilate the nares, pharynx and larynx as well as in the neck and thorax, where they assist in enlarging the rib cage size. A classic example is seen in the nostril flaring of a racing horse. Observation that an animal has accessory muscle activation at rest is a clear sign of severe respiratory disease.

    Exhalation is normally a passive process, and occurs as a result of the elastic recoil of the lungs and rib cage that were "stretched" (by the work of breathing) during inspiration. Active abdominal exhalation in a resting dog or cat is a sign of extensive intrathoracic airway disease and is caused by contraction of (mostly) the external abdominal oblique muscles. Increased expiratory effort is often detected in dogs and cats with small airway disease although the horse provides the best example of this - heaves.

    During inhalation, the respiratory muscles must work to overcome the lung elasticity and frictional resistance to air flow in the air passages. (The inertia involved in moving tissue and gas is minimal, and is usually ignored.) The elastic recoil of the lung is a result of the collagen and elastic tissue in the alveolar septa as well as the surface tension of the fluid lining the alveoli. The elastic recoil of the lung is measured as lung compliance (C =?VT/?P; the units are volume/pressure e.g. ml/cmH2O). In disease, there can be an increase in the amount of collagen within the lung or there can be an increase in surface tension, both of which increase the elastic recoil of the lung (stiffens the lung), reducing compliance and making it more difficult to inhale. Many diseases, such as pneumonia and pulmonary edema, stiffen the lung and cause a reduction in lung compliance. An animal with low lung compliance has difficulty breathing because the lung is more difficult to stretch and expand; this animal will classically breathe more rapidly and more shallowly than normally.

    The second factor to be overcome during inhalation is the frictional resistance of the airways to airflow. In normal animals, approximately 50-70% of total resistance is in the upper airways (implications for our brachycephalic patients!). In the tracheobronchial tree, the majority of resistance is in the central airways (larynx, trachea and bronchi) with the small airways, the bronchioles, contributing very little. For this reason, obstructions of the upper airway or of the trachea and bronchi cause much more severe respiratory distress than obstruction of the bronchioles. Obstruction of the bronchioles must be extensive and severe to cause a major increase in the work of breathing. In respiratory disease, the frictional resistance of the air passages is increased by 1) the presence of obstructions, such as mucus or masses, 2) by the contraction of airway smooth muscle as a result of allergic responses or alterations in autonomic regulation, or 3) as a result of edema in the walls of the airways. Airway resistance can be measured clinically in the anesthetized animal (RL = ?P/?V; its units are pressure/flow, or cmH2O/ml/s). Recent advances in respiratory physiology have allowed for the measurement of airway reactivity in healthy awake cats using a barometric whole-body plethysmograph, a technique that clinicians at Tufts University are working on and which may become available for clinical use in the future.

  2. Distribution - Inhaled air must be distributed throughout the air passages to all alveoli within the lung. The distribution of airflow is determined by a combination of the frictional resistance of the air passages and by local changes in lung compliance. Uneven distribution of ventilation is a major cause of abnormal gas exchange in lung disease. Maldistribution of inspired gas results in an inequality of ventilation to perfusion (referred to as a V/Q abnormality), and clinically to hypoxemia, exercise intolerance and tachypnea for instance.

  3. Diffusion - The transfer of gas between the alveolus and the capillary blood occurs by a process of diffusion. Diffusion is a passive process, depending on a number of factors (Figure 3) including partial pressure differences of a gas on either side of the large surface area of the alveolar-capillary membrane. In disease, these factors can be altered because (for example) the alveoli are flooded with exudates or because of changes of the distribution of blood flow (e.g. pulmonary emboli). Carbon dioxide, because of its greater solubility, diffuses much more readily than O2. Lung disease, therefore, is more likely to cause hypoxemia than it is to cause an increase in CO2 tension.

    The efficiency of gas exchange in the lung is determined by the matching of ventilation to blood flow. In normal alveoli, the ratio of ventilation to blood flow is close to 1, but even in normal lungs there exist regions that have more ventilation than blood flow (more dorsal regions) and some that receive more blood flow than ventilation (the more ventral regions). In small animals these differences are of minor importance. In disease, a wide variety of ventilation to blood flow ratios can exist in the lung. Low V/Q ratio regions of the lung occur as a result of airway obstruction or flooding of the alveoli with exudates. These low V/Q ratio units are extremely common in lung disease and give rise to hypoxemia. Although V/Q is not readily measured, the overall efficiency of gas exchange in the lung can be calculated by measuring the difference between the Alveolar-arterial partial pressure of O2, the DA-aO2 or simply the "A-a gradient" (refer to discussion below).

  4. Perfusion - The blood flow to the gas exchange region of the lung is delivered by the right ventricle, and must be matched to ventilation if a normal V/Q ratio is to exist. When pulmonary vascular disease exists, (e.g. pulmonary hypertension secondary to chronic bronchitis, canine heartworm disease), or when there is a low pulmonary artery pressure, (e.g. shock), the distribution of blood flow can be abnormal and can lead to signs of respiratory disease.
DISEASE CLASSIFICATION: Diseases can be classified into four categories depending on their effect on the respiratory system. Many times a combination of these categories exists. None-the-less, it is important to recognize these, as they may be helpful in the interpretation of the presenting clinical signs.
  1. Obstructive diseases - those that obstruct the movement of air flow into or out of the lungs. Usually associated with increases in airway resistance. Typically results in a slower and deeper respiratory pattern than normal. Clinical examples include: chronic bronchitis, bronchiolitis, compressive tracheobronchial lesions (hilar lymphadenopathy), laryngeal diseases (paralysis, everted saccules, laryngeal collapse, tumor).
  2. Restrictive diseases - those that restrict the expansion of the lungs or chest wall. Usually associated with a decrease in compliance, i.e. stiffer lungs/chest wall. Typically these diseases result in a faster and more shallow respiratory pattern than normal. Clinical examples include: pleural filling defects (accumulations of air or fluid), pulmonary fibrosis, pulmonary edema, pneumonia, and severe obesity.
  3. Diffusion impairment - thickening of the alveolar - capillary membrane. This is difficult to define accurately but is not recognized as a major clinical problem in veterinary medicine.
  4. Pulmonary vascular disease - A serious and increasingly common problem in small animals. Examples include pulmonary hypertension, pulmonary emboli and canine heartworm disease.
RECOGNITION OF RESPIRATORY DISEASE - HX, PX, CLIN PATH, BLOOD GASES, AIRWAY ENDOSCOPY

I specifically avoided the use of the term dyspnea in these talks - because veterinarians can (and should) provide more specific terms when describing an animal's respiratory condition. Dyspnea simply means difficulty breathing and in human medicine is noted when the patient tells the physician that s/he is having trouble/difficulty breathing. It does not give the physician specific information about the cause of the respiratory distress and for this reason I prefer to use specific terms which might provide insight into the underlying etiology. In veterinary medicine we (the veterinary physician) observe specific characteristics that we equate to difficulty breathing and these characteristics should be explicitly stated as they are the terms that relay the detailed information about the patient's condition/problem.

Terms and characteristics which I believe are more informative include those associated with:
  • Rate and volume - fast/slow, deep/shallow
  • Effort - increased or decreased (based on visual, audible or palpable findings)
  • Timing - inspiratory, expiratory; fast, slow
  • Amplitude - quiet, loud
An animal that is being referred to you for "dyspnea" is much better understood with a description of "respiratory distress associated with a marked inspiratory effort and loud wheezing". I encourage you to use these descriptors rather than the more ambiguous global term for respiratory distress.

The basic understanding of respiratory physiology is very helpful (critical?) in the recognition of an animal suffering from respiratory disease. It is the deviation from normal function or dysfunction (e.g. coughing after drinking, increased expiratory/abdominal effort, exercise intolerance etc.) that alerts an owner that there is a problem.

It is the veterinarian's ability to collate and interpret this information (the history) with a careful physical examination and a problem solving approach, which will enable accurate and timely diagnostics and treatment - especially when respiratory distress exists and everyone has been placed in an emotionally charged and stressful situation.
  1. Signalment, or the animal's description - classically the age, breed and sex; it is a useful reminder of common differential diagnoses that might be encountered in a particular animal; a good example is the 11yr old, male Black Lab with inspiratory noise and exercise intolerance. *

  2. History. Many cases of respiratory distress are associated with trauma and the history and observations that an owner can provide can be very helpful. Some cases are secondary to chronic infectious, metabolic/endocrine, toxic or commonly, preexisting cardiac disorders. Inquiring into the animal's previous medical and travel history as well as home/living environment (for instance chronic coughing, exposure to other animals, use as a hunting animal, presence of anticoagulants in the household) may alert you to specific differential diagnoses for consideration. Reading the animal's problem list (assuming this is your own patient that has been seen before) may point out potential concerns relating to a current problem of respiratory distress (such as Cushing's disease, hypoalbuminemia, recent trauma or bite wounds in a cat).

    Table 2 - Findings of auscultation, palpation and percussion in selected pleural and parenchymal disorders. (NB - assumes the patient is sternal or standing)

    DiseaseAuscultationPalpation & Percussion
    Pneumothorax o ? sounds dorsally ("distant")
    o N lung sounds ventrally
    o ? resonance dorsally ("hollow")
    o N resonance ventrally
    Hydrothorax o N to ? lung sounds dorsally
    o ? or absent lung sounds ventrally
    o N resonance dorsally
    o ? resonance ventrally ("solid")
    Pneumonia o Crackles, occ. wheeze
    o ? or absent lung sounds ventrally
    o ? resonance if lobe consolidated
    o ? tracheal sensitivity, moist cough
    Bronchitis,
    "Asthma"
    o Crackles, occ. wheeze
    o Cats - crackles may only be noted post tussively
    o N to ? resonance dorsally
    o Palpable expiratory push/? effort
    o ? tracheal sensitivity
    Pulmonary edema o Fine crackles, esp. ventrally
    o Often note cardiac abnormalities
    o Unknown/no change
    Fibrosis o Fine crackles, prominent dorsally o ? tracheal sensitivity
    Hernia o ? BV lung sounds
    o N to ? heart sounds on N side
    o ? or absent lung/heart sounds on the side of the hernia
    o ? resonance on hernia side
    o ? resonance if stomach is herniated and gas filled
    Mass o Small - no change
    o Large - shift in heart sound location & absence of lung sounds
    o Small - no change
    o Large - ? resonance ("solid") over the lesion
    Lung consolidation o ? BV to bronchial lung sounds
    o crackles, sounds absent if bronchus filled
    o ? resonance over the affected lung lobe


  3. Physical Examination. A quick assessment of an animal's condition upon presentation (triage) is essential. Many animals in respiratory distress have minimal reserves with which to handle the additional stress of transportation, physical examination and diagnostic testing used to determine the underlying cause of their distress. A calm, compassionate approach that deals with the animal's fear, anxiety and possible pain is important.

    If significant distress (open mouth breathing, cyanosis, orthopnea) is present the veterinarian must determine if the cause is airway (e.g. laryngeal paralysis), pleural (hernia, effusion) or primary lung (pneumonia, pulmonary edema) and act accordingly. I use a visual assessment of the respiratory rate, effort (I vs E) and auscultation (pleural air/fluid, crackles, wheezing) to make my initial evaluation. Table 2 summarizes some of the classical findings of auscultation and percussion associated with various airway, parenchymal and pleural filling defects in animals and is a good reminder for us to use both exam techniques in our patients. Be sure to listen to both right and left lung fields, the upper airways (nasal and laryngeal) as well as to the heart for possible cardiac involvement. Table 3 provides a summary of respiratory sounds and reflexes, which might help in assessing these patients.

  4. Diagnostic Tests. There are few routine clinical pathology tests that are specifically diagnostic in respiratory distress situations. A complete laboratory evaluation (CBC, serum chemistries and a urinalysis) none-the-less is recommended as a baseline for future reference/comparison, to rule out co-existing disease and in anticipation of anesthesia if it may be required. A severe left shift, marked eosinophilia, profound anemia, coagulopathy or hypoalbuminemia are examples of abnormal laboratory tests that might relate to a specific cause for an animal's respiratory distress, and if found would warrant further investigation. Parasite evaluation may be indicated depending on your geographical location and the incidence of these parasites in your area - for instance canine heartworm (Dirofilaria immitis).
Arterial blood gas (ABG) analysis is the one pulmonary function test available to all practitioners. Samples are easily obtained and can be run on small portable "point-of-care" units that have become available (e.g. I-Stat, IRMA) or placed in an ice bath and transported to a human hospital for analysis. Iced samples are stable for 4 or more hours - making hospital access feasible for nearly everyone. ABGs also provide important information on the animal's acid-base status and can be used in diabetic ketoacidosis, renal failure, ethylene glycol toxicosis and other metabolic diseases.

Heparinized samples (1-3ml) may be collected from the dorsal pedal or femoral artery. Blood samples should be corked, stored on ice and transported to a laboratory/hospital. Serial blood gas analyses are a sensitive method of evaluating whether there has been any progression or resolution of a given pulmonary disease, I commonly used them to monitor the progression of lung contusion cases as well as chronic bronchitic and pneumonic animals. Radiographic and clinical changes will typically lag behind ABG changes. Classically the values obtained in clinically healthy dogs and cats (depending on elevation - they can be different at altitude) for O2, CO2 and pH are approximately 90-95mmHg, 32-36mmHg and 7.35-7.45 respectively.

The overall efficiency of gas exchange in the lungs may be estimated by calculating the difference in partial pressure between alveolar and arterial O2 values (DA-aO2); in theory a perfect lung would have no difference since all O2 reaching the alveolus would be transferred to the arterial system (see Figure 4). In reality there is a small difference (normally 10-15mmHg). The DA-aO2 may be calculated by using a value of 150mmHg (at sea level) for alveolar O2 in this formula:
DA-aO2 = [150mmHg - (PaCO2 * 1.1)] - PaO2

Chest radiography is probably the most common technique used to diagnose intrathoracic problems and respiratory distress. In respiratory distress cases it is important not to stress the patient excessively just to get these radiographs. Animals with known effusions (air or fluid) should have a thoracocentesis (or chest tube placement) done prior to taking chest radiographs. Pleural effusions not only interfere with interpretation they also endanger the patient who may be stressed obtaining the images. Parenchymal diseases usually cause an increase in interstitial density, which increases with severity to an alveolar pattern and eventually to lobar consolidation. Changes may be patchy, lobar or diffuse. Severe bronchial disease is a common cause for respiratory distress (e.g. "feline asthma", COPD, tracheal collapse). Common terms used to describe the bronchial pattern include "doughnuts" and "tramlines", representing the thickened bronchial walls viewed end-on or from the side respectively. It has been shown that radiographic findings do not correlate well with actual pulmonary function testing.

Thoracic radiography should include views made in at least two planes; lateral and either the VD or DV position. I prefer to obtain 3 views of the chest, both right and left laterals and the VD view for the best evaluation of intrathoracic structures. For optimal demonstration of parenchymal lesions, thoracic radiographs should be obtained at peak inspiration (for dynamic airway lesions both peak inspiratory and peak expiratory radiographs should be obtained). Because the dependent lung lobe contains less air, lesions (some of considerable size!) may be "lost" due to the loss of density difference between the lesion and the deflated (denser) lung lobe. This effect will increase with time but it can happen quickly so that an animal under anesthesia and on its side may completely collapse the dependent lung lobes after as little as 10 minutes time.

To avoid the problem of atelectasis, try to take awake chest radiographs or if under anesthesia and intubated, give the patient positive pressure to re-inflate the lungs. If only a single lateral is obtained it is usually recommended that the left lateral and not a right be taken. If, on the other
hand, abnormal lung sounds are ausculted on examination, then the abnormal side of the chest should be uppermost for a single chest radiograph.

(Table 3 is too large to be portrayed here.)

Table 4 - Preferred Views for Skull Radiography

Area of Interest View
Turbinates Open mouth and/or intra-oral
Sinuses "Frog-eye" or lateral
Maxillary teeth Lateral oblique & intra-oral dental films (best)
Nasopharynx / larynx Lateral - mouth closed, head/neck straight


Respiratory endoscopy (when performed by an experienced veterinarian) is one of the most valuable diagnostics available for the evaluation of airway diseases in dogs and cats. Its application in cases of respiratory distress may be limited by the necessity for general anesthesia and this "cost-benefit" ratio will always have to be carefully evaluated.

Rhinoscopy is the visual assessment of the nasal cavity, nasopharynx (NP) and in some instances the paranasal sinuses. (Bronchoscopy will be discussed later) A complete examination (which includes evaluating both the anterior and posterior portions of the nasal cavity and nasopharynx) requires general anesthesia and specific endoscopic equipment. There are a variety of reasons to consider performing rhinoscopy including complaints of sneezing and reverse sneezing, nasal discharge, epistaxis, abnormal sounds and/or often some degree of airflow obstruction. Animals with epistaxis should have a coagulation profile (e.g., platelet count, PT/PTT and/or a mucosal bleeding time - MBT) performed and their blood pressure checked prior to starting as these patients may have an increased risk of bleeding.

For a complete evaluation of the nasal cavity, sinuses and nasopharynx the assessment should include skull radiographs (see Table 4), rhinoscopy and periodontal probing. Due to strong airway protective reflexes (sneezing and gagging), rhinoscopy requires a deep plane anesthesia, especially for posterior rhinoscopy. Topical lidocaine, sprayed on the mucosal surfaces, may help blunt some of these reflexes. Some degree of patience and practice is required to maneuver a flexible endoscope around the soft palate and into a position to clearly visualize the NP.

When properly positioned the following structures will be visible: the free edge of the soft palate, soft palate, mucosa of the dorsal nasopharyngeal wall, opening to the Eustachian tubes (on the dorsal, lateral walls), choanae, and some of the ectoturbinates in either nasal cavity or vomer bone and the nasal septum. The mucosa should be pink and not friable; there should be minimal secretions and the choanae should be patent.

Typical lesions and abnormalities that I have encountered in the NP include:

  • Mucosal abnormalities: inflammation, hyperemia, increased mucosal fragility or friability, and lymphoid follicle development (an indicator of chronic irritation) or mucosal proliferative lesions (caution - lymphoma in cats can look grossly the same).
  • Decreased amount of space in the NP: due to tumor, polyp, foreign body, stricture, web, excess secretions or even "ectopic" (NP) turbinate development (seen in brachycephalics).
  • Miscellaneous changes: parasites (mites), drainage from eustachian tubes, NP wall abscess.
Once the NP has been examined, the mouth gags can be removed and anterior rhinoscopy performed. The endoscope should initially be directed dorsally and medially (to bypass the bulbous alar cartilage) and then straightened out and advanced into the nasal cavity (parallel to the nasal septum). This will ensure that the scope enters the common meatus and minimizes the potential of trauma to the tissues at the entrance of the nasal cavity. With a small scope and a larger sized animal, it is possible to traverse the length of the nasal cavity and enter into the NP.

The following structures may be visible during anterior rhinoscopy:
  • Opening to the nasolacrimal duct - ventral edge of the alar cartilage.
  • Nasal septum (vertically aligned, opposite of turbinates).
  • Turbinates (dorsal and ventral chonchae), all arise from lateral aspect of the nasal cavity.
  • Four meatii (dorsal, middle, ventral and common) - it is important to note the meatus size!
  • Ethmoidal labyrinth caudally.
  • Maxillary and frontal sinuses - only reached if there has been turbinate destruction/loss.
Anterior rhinoscopy can be made very simple if the size of the air channels (the meatii) or simply the amount of visible space is carefully evaluated. The amount of visible space can only be: 1) normal; 2) increased; or 3) decreased. As in the NP, the anterior respiratory mucosa should be pink, not friable with minimal secretions present.

Typical lesions or abnormalities that I have encountered during anterior rhinoscopy include:
  • Mucosal abnormalities: inflammation, hyperemia, increased mucosal fragility or friability, lymphoid follicle development (less commonly found than in the NP).
  • Increased amount of visible space: turbinate loss, chronic inflammation (usually associated with such conditions as canine nasal aspergillosis or secondary to bacterial infections, e.g., due to tooth abscess, foreign body or feline viral infection).
  • Decreased amount of visible space: the normal air space (meatus) is filled by secretions, tissue (tumor, granuloma, polyp), or foreign body.
  • Secretions: all types.
  • Miscellaneous findings: parasites (nasal mites), fungal plaques.
Cultures from the nasal cavity, although frequently positive, are not recommended as they are thought to be secondary to another problem and usually clear up with minimal antibacterial treatment if the underlying and primary problem is resolved (e.g., tooth root abscess, foreign body). Pinch biopsy forceps may be passed through the endoscope (rigid and flexible) or along side the scope to biopsy a lesion in question using direct visual guidance. Care should be taken to obtain multiple biopsies and to get samples deep within the tissue (to avoid sampling the necrotic edge of a lesion). In the JAVMA study by Lent and Hawkins 83 of 94 cases (88.3%) had a definitive diagnosis made using gross rhinoscopy and rhinoscopic assisted biopsy. Touch imprints for cytology can be reviewed while awaiting histopathology results.

Laryngoscopy is the gold standard for assessing laryngeal disease as it allows for the evaluation of both anatomic lesions as well as disorders of intrinsic laryngeal function/motion. Although routine equipment may be used (tongue depressor, light source), I firmly believe that using an endoscope allows for a more detailed evaluation of the larynx as well as allowing you to look into the NP and down into the trachea for any co-existing problems. Prior to anesthetizing the animal, be sure to evaluate for any loss of sensory function (gag reflex) in the oropharynx as this may be associated with an increased risk of future aspiration (especially important if laryngeal surgery is anticipated). Classically, a light plane of anesthesia (ideally so the animal is still gagging) has been recommended when evaluating the larynx. Following assessment of the laryngeal anatomy I routinely use a respiratory stimulant (doxapram HC1, Dopram-V, 2.2 mg/kg BW IV) to overcome concerns about anesthetic depth and to maximize intrinsic laryngeal motion; the onset is fast, usually within 15-30 sec, with a duration of 2-3 minutes. The use of Dopram has allowed for a deeper plane of anesthesia initially and a better assessment of subtle anatomical abnormalities while still being able to assess intrinsic laryngeal function.

Typical lesions that I have observed in the pharynx/larynx during laryngoscopy include:
  • Elongated soft palate: should be anticipated and resected at the time of scoping if possible.
  • Laryngeal mucosal edema: this can be severe in animals with a chronic history of upper airway noise (again, anticipate in those with known problems such as brachycephalics).
  • Edematous/everted laryngeal saccules (lateral ventricles): eversion can be very dynamic so look closely at rest as well as following Dopram administration!
  • Laryngeal paralysis: may be unilateral or bilateral.
  • Laryngeal collapse: a life threatening complication of chronic upper airway obstruction.
  • Laryngeal neoplasia: lymphoma, squamous cell carcinoma are the most common types.
  • Epiglottic entrapment: secondary to other inspiratory problems; may be intermittent.
Biopsies may be taken under direct visualization. Edema may result from vigorous laryngeal manipulation and should be treated with corticosteroids following completion of the procedure. Severely obstructive lesions may require the placement of a temporary tracheostomy to maintain a patent airway while ancillary measures are taken to treat the obstruction (corticosteroids for edema, laser resection of mass lesions, or perhaps definitive surgery for laryngeal paralysis).

Bronchoscopy has been an integral part of respiratory practice in veterinary medicine since at least the early 1970s. There is no question that bronchoscopy (including bronchoalveolar lavage for cytology and culture) is the gold standard for the diagnosis of lower respiratory tract diseases in small animals. Bronchoscopy may be used for diagnostic, therapeutic and prognostic purposes. Diagnostic bronchoscopy obtains visual information concerning the airways (e.g., compression, dynamic collapse, dilation) as well as samples (cytology, culture, and occasionally biopsy) to help establish a specific etiologic diagnosis. General anesthesia is necessary to control airway reflexes during bronchoscopy, thereby preventing trauma to the airways, and at the same time protecting the endoscope throughout the procedure. The ideal anesthetic should provide good patient restraint, have minimal cardiorespiratory effects, be either reversible or of short duration and allow for a smooth recovery period. The availability of newer, short acting and/or reversible injectable anesthetics has allowed bronchoscopy to be performed on patients with minimal concern. My current anesthetic protocol utilizes either atropine or glycopyrolate, with either acepromazine or butorphanol for premedication; valium and propofol are used for the anesthetic procedure. I prefer not to intubate my patients until the recovery phase of the procedure. This form of anesthesia is very beneficial because it not only provides adequate anesthesia for the procedure, but also allows for rapid patient recovery, an important factor in geriatric patients.

The bronchoscopist must have a good understanding of normal endoscopic lung anatomy (Figure 5) if she/he is to recognize subtle abnormalities and diseases. The differentiation (recognition) of normal from what is abnormal is a subjective one. Experience and practice greatly improve the clinician's ability to detect lesions at an early stage. I routinely examine the larynx (anatomy and intrinsic function/motion if possible), the cervical and intrathoracic trachea and then the carina before sequentially evaluating all the lobar and finally as many segmental and/or sub-segmental bronchi as possible (the latter varies with patient and endoscope size). Changes in gross anatomy, fixed and dynamic lumen size, abnormalities in airway shape, mucosal/submucosal characteristics, and the presence of secretions should be noted. Experience and practice will improve an endoscopist's ability to detect early lesions. Samples obtained (cytology, culture, and biopsy) are then relied upon to establish a specific diagnosis.

Bronchoalveolar lavage (BAL) is essentially a washing of the distal airways and alveoli. Material obtained from this area is thought to be representative of the distal airways, alveoli, and the intersitium of the lungs. The bronchoscope (or catheter) is advanced distally and gently wedged in a selected bronchus and then 10-20ml of sterile saline is flushed into the airways and immediately aspirated using gentle syringe suction. I try to use two aliquots per site and two sites per animal. The sites are evaluated individually with total cell counts and a cytospin for differential cell counts but I combine the fluid for a quantitated BAL culture. Difficulties with the procedure (poor returns) may be expected when a proportionately large endoscope prevents wedging in a smaller bronchus, or when the airways are malacic. In the former situation, the fluid is dispersed into too large an area to be easily retrieved, and in the latter, the airways collapse (even with gentle suction), preventing the return of any significant volume of the infusate. The predominant cell in all species should be the alveolar macrophage (70+), with approximately 3-8% of all other cell types (except the cat which may have up to 20%+ eosinophils and still be considered healthy). Many pathologists interpret this BAL cell differential as "granulomatous" in nature but that is incorrect! Macrophages are the normal cell to be seen on a good BAL.

Cultures from the lower airways are helpful in establishing a specific diagnosis and selecting an appropriate antibiotic based on sensitivity results. Gram stains help in interpreting culture results and provide early insight into correct antibiotic selection. Contamination resulting from the mixing of upper respiratory tract secretions with lower airway samples must obviously be avoided. (finding squamous epithelium and/or the large bacterium Simonsiella spp. (Figure 6) both are indicative of oral cavity contamination). Peeters recently showed that quantitated BAL cultures are important in the differentiation of airway colonization from actual infection. Mycoplasma cultures are possible using specialized transport media (e.g., Amies media) and overnight shipment to selected laboratories. Microbiological results must always be interpreted in light of the cytology obtained from the same site.

NASAL, NASOPHARYNGEAL AND LARYNGEAL DISEASE

Signalment. Nasal, nasopharyngeal (NP) and laryngeal disorders are common causes of upper airway respiratory distress. Airflow obstruction is the problem in all these conditions. Laryngeal disease is perhaps more common than you realize in small animal practice, and includes such problems as the brachycephalic airway syndrome, laryngeal paralysis (in both dogs and cats!), and neoplasia. Clinical signs associated with these regions however are similar and will be discussed together.

History. There are a variety of presenting complaints that are associated with upper airway problems, including:
  • Sneezing and reverse sneezing (also called the "aspiration reflex," a normal response to any irritation of the dorsal nasopharyngeal mucosa).
  • Nasal discharge: determine type (serous, mucoid, purulent, bloody etc.), amount, frequency, whether (when it was first noticed) unilateral or bilateral, if the character has changed, and if it is worse at any specific time of the day. The discharge may sometimes be due to chronic pneumonia or vomiting (secretions are thrown or coughed into the nasopharynx, and then noticed as a nasal discharge).
  • Respiratory sounds/noise: does the animal make any sound while breathing (with exertion or while sleeping)? Sounds which are new or only recently noted are likely important indicators of airway obstruction. Ask if there are any voice (bark, meow/purr) changes (laryngeal disorders?).
    • Stertor, a snoring sound, due to an intermittent physical obstruction usually heard on inspiration (e.g., soft palate, NP mass).
    • Snorting, found with obstructions secondary to accumulated secretion (e.g. nasal).
    • Stridor, an inspiratory wheeze or noise, typically associated with high cervical tracheal/laryngeal airway narrowing lesions.
  • Exercise intolerance - usually accompanied by an increased inspiratory effort and often with pronounced stridor.
  • Open mouth breathing - may indicate bilateral nasal and/or nasopharyngeal obstruction.
  • Cheek puffing - often noted on expiration with NP obstruction (e.g. masses)
  • Coughing after eating or drinking.
Physical examination - I test for airway patency through, and estimate airflow from, each nostril separately - often using the bell on my stethoscope to listen to airflow. At rest, a healthy animal should be able to breathe without distress through one nostril when its mouth is held closed. If there is any change in effort or noise associated with single nostril breathing, I assume there is some degree of obstruction. Look at the type of discharge and ask the owner how this may have changed over time (response to previous treatments etc.). Facial deformity and/or periosteal pain may be indicative of bony or periosteal involvement-often associated with tumor, fungal infections, or occasionally abscessation of a tooth. Signs of pharyngeal disease usually are associated with airflow interference and/or the presence of a nasal discharge. Open mouth breathing (without difficulty) in the face of bilateral nasal obstruction is typical.

Specific diagnostic tests include:
  • For epistaxis: look at platelet numbers and function (mucosal bleeding time), PT/PTT as well as arterial blood pressure (for systemic hypertension); check medication history for aspirin and/or the use of alpha agonists.
  • For feline calici virus (FCV): only available by virus isolation at this time.
  • For feline herpes virus (FVF), Chlamydia and Mycoplasma: PCR tests are available to help diagnose these agents. The test may be performed on either a conjunctival scraping or tissue (conjunctiva or nasal) biopsy; transport media is required (sterile saline often works).
  • For nasal fungal disease: canine aspergillosis - fungal serology is not a sensitive test; for feline cryptococcosis the Latex agglutination test has good sensitivity.
  • Dental evaluation - under anesthesia do complete periodontal probing, dental radiographs.
  • For any nasal, NP or laryngeal disorder - the best tests include:
    • radiography (skull and dental radiographs as well as CT and MRI which have particular application to nasal and sinus disease), and especially
    • complete periodontal / dental examination
    • endoscopy (see discussion above).
Examples of upper airway problems that may present in respiratory distress include:
  • Reverse sneeze: this is a normal reflex to the irritation of the dorsal wall of the nasopharynx, and characterized by the sudden onset of forceful and paroxysmal inspiratory efforts. Although not a serious problem for the animal, if is a common cause of concern to owners! There is no specific treatment (except for an underlying cause if found - nasal mites are a common cause in my experience). NP inflammation (including severe follicular pharyngitis) is associated with reverse sneezing. Any irritant can be the trigger for this reflex. If no specific trigger can be found I will often prescribe a trial therapy of an anti-inflammatory (steroids or piroxicam).
  • Nasopharyngeal stenosis or webbing: A problem in cats (primarily) of any age; this is a transverse sheet of scar tissue formed above the soft palate and obstructing the flow of air through the NP. Typically has a small pinhole size opening for airflow. Webbing is believed to result during the healing process after various injuries to the air passages (infectious, traumatic). Scar tissue has also been observed within the nasal cavities. Diagnosis is best made via direct visualization (rhinoscopy). Treatment is to surgically resect the lesion, usually via splitting the soft palate, removing the web and closing the palate. Complications include dehisence of the palate and reformation of the web. Recently success has been reported using a ballooning technique to break the web down. The difficulty with any of these procedures is to prevent the scar tissue (web) from reforming again.
  • Nasal foreign bodies - in my experience, the majority of these cases involves material that the animal has mouthed and then when trying to get rid of it has thrown it up into the NP; caudal (flexible) rhinoscopy is needed to identify and deal with these cases. Vigorous nasal flushing with sterile saline is helpful in removing these.
  • Brachycephalic airway syndrome. I am continually amazed at the severity of inflammation that is seen in these cases. The syndrome includes or is associated with a number of specific problems; these airway problems should be aggressively dealt with early in life to prevent the onset of irreversible airway changes:
    • Stenotic nares - resect if they are narrowed and there is paradoxical inspiratory motion.
    • Elongated soft palate - the most common problem, I recommend that all brachycephalic dogs have this corrected when they are neutered if not sooner if indicated (along with other abnormalities identified on examination).
    • Laryngeal edema - some degree (often severe) of edema will be present in almost every case; steroids are indicated following surgical correction of these problems and in many cases should be given prior to surgery in attempt to reduce airway inflammation. Chronic edema can lead to fibrosis over time (many dogs suffer from years of inflammation).
    • Everted laryngeal saccules - these are secondary to other problems but with time they can become fibrotic and not resolve following removal of the other (inciting) airway problems.
    • Laryngeal collapse - an end stage process caused by cartilage failure secondary to long standing inflammation and inspiratory effort; prognosis for these dogs is grave.
    • Tracheal hypoplasia - I recommend checking all brachycephalic dogs for this (a straight lateral chest radiograph) prior to any upper airway surgery.
    • Enlarged tonsils - these can be quite large secondary to chronic irritation and should be removed if they contribute to airway obstruction when examined.
    • NP turbinates - normal nasal turbinates which extend into the NP during development and appear to act as another site of airway obstruction in these dogs.
  • Laryngeal paralysis - this is a common problem in large breed dogs (as an acquired, slowly progressive neuropathy), as well as in some breeds of dogs as a congenital problem (the Bouvier, Siberian Huskies, Dalmatians etc.). Cats can also be affected - I will see 6-10 of these each year. Dopram administration will assist in assessing intrinsic laryngeal function and should be a standard part of any complete laryngoscopy. At our hospital we have begun to evaluate these cases more critically at the time of diagnosis to include an evaluation of the site of obstruction (vocal cords or arytenoids?), the degree of arytenoid motion (fixed and rigid or easily abducted?) and the location of the upper esophageal sphincter in attempts to define criteria for selecting the best surgical technique for treating them. Laryngeal surgery is only recommended when respiratory distress is severe due to the high incidence of aspiration pneumonia that has been reported (approximately 25%). Surgical procedures include the standard arytenoid "tie-back" surgery as well as laser procedures (vocalcordectomy and partial laryngectomy in cats). The risks of intra-laryngeal surgery have always been subsequent scarring (granulation tissue); the topical use of Mitomycin-C (an older chemotherapeutic agent) has shown great promise in preventing this potential complication and we use it routinely in these cases.
LOWER AIRWAY AND PARENCHYMAL DISEASE

When I was sitting in class some (!) years ago, it was questioned whether naturally occurring chronic bronchitis (CB) occurred in dogs, but now is recognized as a common disease of varying degrees of morbidity. CB is the term initially applied by Wheeldon in 1974 to describe the pathology in dogs associated when chronic coughing has occurred for two or more consecutive months during the proceeding year and which is not attributable to another cause (e.g. neoplasia, CHF). It also implies a non-reversible (indeed it is normally a slowly progressive) condition. Both dogs and cats develop CB, and the 2 month time course has been generally extended to apply to cats as well as to dogs.

History. Coughing is the hallmark of lower airway disease. Tracheobronchitis (acute and chronic) typically has the dry, hacking, non-productive cough; post-tussive gagging is common and owners often misinterpret this as "vomiting". Pneumonia is associated with the moist, productive cough. Another major difference is that tracheobronchial disease usually has few if any systemic signs (lethargy, anorexia, fever, depression). Coughing may occur at any time during the day but is common following exertion (exercise intolerance), at night (nocturnal coughing) as secretions accumulate, or when if the trachea is irritated - for instance with "leash pulling". Wheezing, breathing with an expiratory effort, exercise intolerance, cyanosis and even syncope may be noted.

Physical examination. With pre-existing tracheal irritation/inflammation, any additional irritation (by palpation or manipulation) of the trachea normally results in coughing; this "increased tracheal sensitivity" is a non-specific indicator of existing inflammation. The large inspiration required to generate a cough can be used to listen for crackles as they tend to occur on inspiration. An expiratory abdominal push (increased effort during quiet/resting breathing) and/or end-expiratory wheezing are characteristics encountered in patients with severe small airway disease. Most CB animals are bright, alert and afebrile. Bronchovesicular lung sounds and end-inspiratory crackles are commonly heard. Wheezing may be noted, especially when airflow initially moves through airways obstructed by secretions. An end-expiratory "snap" may be heard in dogs with decreased cartilage rigidity as the increased intrathoracic pressure generated with an active expiratory effort often collapses central airways (normal airways will narrow but do not collapse) and the airway walls literally "snap" together. Active abdominal (external abdominal oblique muscle contraction) during quiet breathing is an excellent indicator of small airway disease. See Table 3 for a complete summary of respiratory sounds and reflexes.

In cats with CB, lung sounds may be normal at rest but (post-tussive) crackles become prominent after coughing is induced as secretions are loosened. Tracheal sensitivity should be evaluated in all patients. Tachypnea is a more frequent primary complaint in cats than in dogs with CB.

A careful cardiac examination is important in order to differentiate heart disease from CB; in many cases this can be difficult to do. Murmurs secondary to valvular insufficiency are common in older, small breed dogs (but not in cats); these cases must not be misinterpreted as being in CHF. A simple but fairly accurate method of determining whether CHF or CB is present in the dog (less so in the cat) is to examine the resting heart rate; CHF is associated with an elevated heart rate while CB usually results in a normal to slower heart rate due to vagal stimulation.

Differential diagnoses for an animal presented in respiratory distress and with a history of coughing, crackles, exercise intolerance and a murmur include: bronchitis, pneumonia, bronchiectasis, aspiration secondary to laryngeal dysfunction, allergic lung disease, compression on a mainstem bronchus (LAE, hilar lymphadenopathy), foreign bodies, pulmonary hypertension, HW or other cardiopulmonary parasitic disease and primary cardiac problems.
Diagnostic tests for patients with suspected lower airway disease/respiratory distress include:
  • ABGs - These are easy to do and provide the only functional assessment of overall lung function available in practice.
  • Parasite evaluation - fecal exam(s), HW testing (endemic areas, dogs with a travel history)
  • CBC - Useful in those with systemic signs (pneumonia cases primarily). Less than 40% of confirmed allergic airway cases (those with eosinophils on airway cytology) have an absolute peripheral eosinophilia. Be careful - pneumonia can exist and be severe despite a normal CBC!
  • Radiography - Thoracic radiography provides one of the most widely available methods for evaluating the tracheobronchial tree and lung parenchyma. Bronchial disease normally demonstrates the thickened bronchi ("donuts", "tram lines"). Parenchymal diseases usually cause an increase in interstitial density, which increases with severity to an alveolar pattern and eventually to lobar consolidation. Changes may be patchy, lobar or diffuse. Remember however that functional changes and visible structural changes do not always parallel each other.
    • Thoracic radiography should include views made in at least two planes; lateral and either the VD or DV position. I prefer to obtain 3 views of the chest, both right and left laterals and the VD view for the evaluation of lung diseases.
    • For optimal demonstration of parenchymal lesions, thoracic radiographs should be obtained at peak inspiration (for dynamic airway lesions both peak inspiratory and peak expiratory radiographs should be obtained).
  • Airway cytology is necessary to determine an etiologic diagnosis and in order to recommend the most appropriate/specific therapy. Samples may be obtained via transtracheal wash, fine needle lung aspiration or bronchoalveolar lavage during bronchoscopy. Samples should be examined both cytologically as well as by culture and sensitivity determination. Extensive cytology experience is not required in order to differentiate between many of the common causes of coughing. Each technique has reasons pro and con as well as different risks associated with the procedure.
    • Transtracheal aspiration biopsy (TTA) is indicated in acute (when a culture is needed) or in chronic lower respiratory tract diseases when other routine tests have failed to establish a diagnosis. A large bore (e.g. 16ga), "thru-the-needle" type jugular catheter, 3 way valve, sterile saline, syringes and microscopic slides are all that is required. Lidocaine (2%) is sufficient for local anesthesia; general anesthesia should be avoided due to cough suppression. When properly placed the tip of the catheter should be just proximal to the carina. Care must be taken if a trans-oral technique is used in order to avoid oral cavity contamination. The amount of fluid injected will vary with both the disease and the size of the patient. I typically inject 3-5 ml aliquots of sterile saline and, after the animal has coughed, aspirate until a visible sample is obtained (repeat as needed to obtain a sample). A trans-oral approach (passing a catheter through a sterile trach tube) may be used as well (be careful to avoid contamination with oral secretions).
    • A fine needle lung aspirate (FNA) is indicated when there is diffuse lung disease or when a large region of lung is diseased (e.g. lung mass or consolidated lobe). The aspirate should be obtained from a region identified by radiography, using a small gauge needle (typically a 1-1.5" x 22-25 ga. needle) and a 6 ml syringe. The needle should be inserted in front of the rib and (with respiration stopped) thrust into the lung, aspiration applied and then the needle quickly withdrawn. Only a small sample (perhaps enough for 1 or 2 cytology slides) will normally be obtained although repeated samples can be used to obtain material for culture. Be careful performing a fine needle lung aspirate in an animal with an active expiratory effort as the risk of inducing a pneumothorax is increased.
    • Bronchoscopy with full BAL is my preferred method of collecting samples from the lower airways (see discussion above).
  • Electrocardiography (ECG) an Echocardiography (Echo): One of the major differential diagnoses for the coughing animal is primary heart disease. Chamber enlargement due to volume overload may be associated with pulmonary edema and coughing. LAE may induce coughing directly by direct compression of the left principal bronchus (visible on lateral chest radiographs and at bronchoscopy). Enlargement of other chambers, e.g. the RA and RV, have been associated with chronic lower respiratory tract diseases and the development of cor pulmonale.
  • Thoracotomy - if other diagnostics have failed to establish a firm diagnosis exploratory surgery should be considered. Thoracoscopy is beginning to be used to obtain lung biopsies for histopathologic confirmation of the lung problem.
Examples of lower airway problems that may lead to an animal presenting in respiratory distress include:
  • Chronic bronchitis - A specific etiology for CB is rarely determined. Chronic airway inflammation leads to chronic coughing. The primary effects on the respiratory system are hypoxemia, exercise intolerance and respiratory distress.
    • Recurrent airway inflammation (e.g. infections, inhaled irritants) is suspected. Acute exacerbations are commonly superimposed on a chronic course. Persistent tracheobronchial irritation results in chronic coughing and changes in the epithelium and wall of the tracheobronchial tree. Mucus production is increased due to changes in glandular structures as well as goblet cells. Other commonly reported changes include airway inflammation, epithelial edema, thickening and metaplasia. Airway narrowing (with the associated increase in resistance and decreased expiratory air flow rates) is the net effect of these changes. In severe cases the work of breathing increases and is detected as respiratory distress (an increase in breathing rate/effort, disproportionate to the patient's level of exertion).
    • Changes in the histochemical structure of the cartilaginous rings in the trachea and/or the plates in the bronchial walls result in a weakening of the wall and collapse of the affected airways (tracheobronchial malacia or tracheal collapse when the trachea itself is affected). Secondary effects on the heart (cor pulmonale) may lead to pulmonary hypertension and may be severe. Syncopal episodes are frequently reported in dogs with chronic coughing due to decreased blood flow thorough the brain. Hepatomegaly secondary to passive congestion may occur.
    • CB is typically thought of as a small/toy breed dog problems, but it is also commonly observed in large dogs. Bronchiectasis has frequently been observed in young to middle aged Cocker Spaniels following a long history of CB. Siamese cats have been reported to be more frequently and more severely affected than other breeds of cats. CB most often affects middle aged and older animals. Ciliary dyskenesia is usually reported in young dogs and results in chronic bronchial disease (including bronchiectasis) due to poor secretion clearance and recurrent infections. A female sex predilection has been suggested by some authors in feline CB, but not our studies. No sex predilection has been noted for canine CB. The patient's body condition score (BCS) should be determined as obesity is a common and significant morbidity factor in canine CB.
  • Tracheal collapse - I believe that this disorder is brought on by small airway disease leading to the previously described histochemical changes in the cartilage which allows collapse to occur as increased intrathoracic pressures are generated to facilitate exhalation. The medical treatment of these cases is very similar to the treatment for CB. Diet is critical and these animals must be prevented from becoming obese. Selected cases of tracheal collapse may benefit from surgery; careful examination of the airways (bronchoscopy) is needed to select these cases. The placement of external plastic ring supports has been used with good success in selected cases. Recently tracheal stents have been reported in tracheal collapse cases but should be only considered in very severe cases and are associated with potential complications (granulation tissue formation). Severe dental disease should be treated aggressively to minimize secondary bacterial showering of the lower airways in these and in CB patients.
  • Pneumonia - various types (viral, bacterial (primary, secondary to foreign body, aspiration etc.), fungal, parasitic etc.) exist and are discussed below.
  • Pulmonary fibrosis - West Highland White Terriers have been noted to develop a progressive disorder characterized by chronic coughing, tachypnea and crackles. The location of the pulmonary infiltrates as well as the location of audible crackles seems to be more caudodorsal than in other bronchitis cases. Fibrosis is thought to be present in these cases but detailed clinical and pathologic studies of the condition are lacking. Lung biopsy is needed to confirm this diagnosis. Treatment is typically the same as for CB cases.

    Neoplasia - We encounter primary and metastatic tumors on a regular basis. Three view chest radiographs are indicated in order to fully evaluate all lung fields for involvement. Diagnosis is based on cytology or histopathology from a tissue biopsy. Abdominal ultrasound is indicated to ensure that there are no distant primary sites before surgery is considered. Surgical intervention for suspected primary lung tumors is recommended as early in the disease process as possible. The median survival time for primary lung tumors varies significantly based on whether the hilar lymph node is involved or not - always have a hilar node biopsied as part of the surgery.
  • Foreign body - On occasion an owner will witness and know that a foreign body (FB) was aspirated; usually it is the ensuing pneumonia that alerts us to this possibility. The animal's use (i.e. a hunting dog that runs in fields) is an important part of the history and can alert the veterinarian to this possibility. Diagnosis is based on finding the FB, on bronchoscopy or at the time of surgery (lung lobectomy). Treatment for the ensuing bacterial pneumonia (see below) is important following removal. Bronchiectasis may develop secondary to the FB being in the bronchus and even if it can be removed bronchoscopically a lobectomy may be required to fully resolve the pneumonia.
PNEUMONIA. Defined as inflammation of the lung parenchyma (interstitium and alveolar tissues), pneumonia has many potential causes including viral, fungal, bacterial or parasitic. The systemic fungal diseases are limited to select geographical regions of the world but on occasion are encountered elsewhere due to our highly mobile/traveling population. Parasitic pneumonia is more of a hypersensitivity response due to migration of larvae through the lung; primary lung parasites are much less common. Although viral infections may result in a diffuse interstitial pneumonia, it is the secondary bacterial infection that we see clinically in dogs, and what we end up treating. Normally host pulmonary defense mechanisms protect against bacterial infection but pneumonia may ensue when defenses are depressed (e.g. secondary to a viral infection, steroid immunosuppression), when they are grossly altered (e.g. bronchiectasis, foreign body) or are simply overwhelmed (for instance the typical aspiration pneumonia).

The diagnosis of pneumonia should be suspected when there is a history of a productive cough, and you are presented with a sick animal (depressed, lethargic, inappetent, febrile). Systemic changes are to be expected (as opposed to bronchitis where they are atypical); fever and an elevated WBC (± left shift) are common but not always present. Confirmation is best based on chest radiographs (showing the typical alveolar infiltrates) and analysis of samples from the airways (for culture/sensitivity as well as cytology) - obtained either by transtracheal wash (TTW) or bronchoscopy with bronchoalveolar lavage (BAL).

My preference is for BAL over TTW since this procedure also allows for a visual assessment of the entire respiratory tract and for selective sample collection. While upper airway infections are usually Gram positive in nature, most lower airway infections involve Gram-negative organisms. Care must be used to ensure significant bacterial numbers are cultured (I recommend doing quantitated BAL cultures) so as to differentiate airway contamination (insignificant bacterial numbers) from true infection. Mycoplasma cultures can be easily run through at selected laboratories (Universities?) using special (Amies) transport media. Cytology greatly aids in this interpretation, as intracellular organisms will be readily encountered when there is significant bacterial growth. Arterial blood gases are an excellent way to document the functional severity of the pneumonia and to monitor response to treatment over time.

Treatment for bacterial pneumonia is aimed at clearing the infection, decreasing/removing secretions and improving alveolar ventilation and gas exchange (blood gases). Antibiotic choice is best based on sensitivity results. Initial selection of an antibiotic with a good Gram-negative spectrum and good penetration into the lungs is indicated. My preferred initial choices include amoxicillin/clavulanate, cephalosporin, one of the fluoroquinolones and in severe life threatening infections a combination of amoxicilin and an aminoglycoside. Treatment should continue for a minimum of 3-4 weeks, longer in recurrent infections (cases of bronchiectasis may require intermittent therapy for months and even years). Adequate systemic hydration must be maintained to prevent secretions from drying out.

The use of diuretics is contraindicated in the presence of excess secretions as this will dry airway secretions and lead to secretion retention and potentially airway obstruction. When there is consolidation or significant secretion retention I recommend increased activity to facilitate secretion clearance. In severe cases intermittent positive pressure breathing (IPPB) treatments using a facemask and a ventilator have been helpful in our practice. Relapses are most often associated when an underlying disease such as megaesophagus, laryngeal disease or bronchiectasis is present - additional diagnostics to look for these and other underlying causes are indicated when relapses are noted to be a common problem. Long term or intermittent antibiotic therapy may be required when persistent or recurring pneumonias occur. Attention to other nursing items (nutrition, warmth, cleanliness) is also a major factor in the recovery of these patients. Surgical lobectomy has been used in a few cases when the nidus of infection is shown to be a single lobe.

RATIONAL PHARMACOLOGY FOR AIRWAY AND PARENCHYMAL DISEASE.

Which antibiotic is best? Are bronchodilators effective? How long do I treat for? Should I use steroids? Are there newer drug delivery systems and equipment that I should consider? Is there any information that says one particular protocol is better than another or that this drug really works?? Yes, therapeutic choices can be difficult and confusing. Establishing a specific diagnosis however makes treatment selection much easier. There are three general goals of respiratory therapeutics that I will talk about: 1) the control of secretions - treating the underlying problem, 2) the maintenance of alveolar ventilation (ensuring adequate tissue oxygenation) and 3) the normalization of pulmonary (excessive) reflexes.
  1. Control of secretions: Secretions may be controlled by either decreasing their production (the best choice) or increasing/facilitating the removal of excess, accumulated secretions.
    • Specific methods of controlling secretions
      • Methods of decreasing production of secretions: Antibiotics and corticosteroids - culture and cytology are the main methods in determining when each is indicated.
        • Cultures - Bacterial cultures from the upper airways (nasal cavity) are rarely helpful as infections there are secondary; cultures for lower airway disease must be obtained from the lower airways, tonsillar swabs are not indicative of flora in the lower airways. Chronic bronchitis is not normally associated with significant bacterial growth (see discussion on quantitated cultures).
        • Drugs -
          1. Antibiotics: Use bactericidal antibiotics that have a good spectrum of activity. A Gram (Gm) stain is helpful in determining an antibiotic, although each case should have it's own sensitivity if possible (especially if you observe Gm negative organisms). For upper airway diseases antibiotics with a good Gm positive spectrum are best. Most pathogens in the lower airways (~85+ %) are Gram negative (e.g. E. coli, Klebsiella, Pseudomonas spp. etc.). Cephalosporins, potentiated sulfas, amoxicillin or amoxicillin/clavulanate, and fluoroquinolones are usually good choices for lower airway infections.

            The route of administration is a concern for lower airway diseases. If the infection is thought to be tracheobronchial (intra-luminal) then there should be concern about antibiotic penetration into the lumen of the airways (i.e. does the antibiotic actually penetrate into bronchial secretions). Intratracheal injections or aerosolized antibiotics may be helpful in selected cases of infectious tracheobronchitis (specifically those due to Bordetella infections).

          2. Corticosteroids - These drugs constitute an important treatment option for allergic diseases as well as in chronic bronchial disease to decrease cellular infiltration (see Figure 6). Oral short acting steroids (prednisone) are preferred for ease of dosage adjustments which is import in chronic conditions. Inhaled steroids are also being used more frequently (see discussion below).
          3. Antifungals - With the availability of new oral antifungals (itraconazole, fluconazole), effective antifungal therapy can be accomplished at for most infections (e.g. cryptococcosis). Topical treatment (enilconazole, clotrimazole) is preferred for nasal aspergillosis in dogs.
    • Non-specific methods of controlling secretions. Non-specific means of removing secretions including methods designed to "loosen" secretions (e.g. aerosol therapy and expectorants) and those which are designed to improve the rate of their clearance from the tracheobronchial tree (e.g. cough facilitation and chest physiotherapy) should be used. Agents which "dry up" secretions may be tried when other means have failed (often chronic, bilateral mucoid nasal discharge cases).
      • Aerosol therapy: Goal is to loosen secretions. Always used in conjunction with physiotherapy. Efficacy is debatable. Antibiotics should NOT be aerolosized unless it is directly via a facemask and then are indicated only for airway (not parenchymal) infections. Ensure adequate systemic hydration before using aerosol therapy.
        • Equipment - Ultrasonic nebulizers are best; they produce particles of between 0.5-3 micra in size which are best for deposition in the lower respiratory tract. The new Nebulair unit (DVM Pharmaceuticals) is useful for short term, face-mask nebulization.
        • Fluid - bland aerosol therapy using sterile 0.9% NaCl.
        • Technique - aerosol therapy for 30-45 minutes (using a larger ultrasonic unit), 2-4 x/day in a closed cage followed by physiotherapy has seemed beneficial in many cases of lobar pneumonia.
      • Physiotherapy: designed to increase clearance by:
        • improving tidal ventilation (mild forced exercise, IPPB) - provides a milking action to the tracheobronchial tree which facilitates secretion clearance.
        • increasing the frequency of coughing (manually stimulating a cough reflex via chest wall coupage, vibration, or tracheal manipulation), or
        • assisting gravitational drainage of secretions (postural drainage is done in human medicine, not practical for us).
      • Expectorants: In principle an excellent idea; poor in reality.
      • Decongestants - Designed to dry up secretions, I use them rarely, only when a specific diagnosis was not obtained and the discharge persists and is a problem for the owner. Alpha agonists (pseudophed 0.1-0.4mg/kg BID-TID, PO) may help.
      • Some nasal conditions result in structural abnormalities (nasal polyps, nasopharyngeal webbing) leading to airflow obstruction and must be treated surgically. Destructive rhinitis in cats following chronic viral disease may be associated with significant retained secretions and benefit from simple saline administration (aerosol or nose spray).
      • Non-specific airway inflammation (irritation) is one problem which I commonly encounter in the Denver area and which seems to be very difficult to resolve. It is typically characterized by sneezing and a bilateral, slightly opaque to whitish nasal discharge. Diagnostics to document an underlying problem are unrewarding; biopsies show the non-specific lymphoplasmacytic rhinitis we have grown to hate. Anti-inflammatory therapy (steroids or NSAIDs) may be used, at least on a trial basis. A change in dog's environment may also help.

  2. Maintenance of alveolar ventilation: Adequate alveolar ventilation is the principal requirement for normal blood gases, tissue oxygenation and acid-base balance. Arterial blood gas analysis is required to quantify these abnormalities. Hypoventilation (inadequate alveolar ventilation) leads to the accumulation of carbon dioxide, hypoxemia, and respiratory acidosis. Hypoventilation may be caused by 1) damage to the central nervous system (coma, drugs), 2) injury to the peripheral nerves (laryngeal/diaphragmatic paralysis), 3) damage to the respiratory pump (diaphragmatic hernia, fractured ribs, muscle fatigue), or 4) primary respiratory disease (parenchymal and airway disease).

    Animals with disease of the lung parenchyma often manage to maintain alveolar ventilation and eliminate carbon dioxide, but do so at an increased cost (work of breathing). Measurement of the DA-aO2 (difference in partial pressure of oxygen between the alveolus and the arterial blood) is a sensitive way to detect abnormalities in the overall efficiency of gas exchange in the lungs. Respiratory failure is often described in terms of the ABGs, specifically a PaO2 less than, or a PaCO2 greater than 60mmHg. The restoration of adequate blood gases in an animal with respiratory problems should be directed at eliminating the specific cause of the disease. Ventilator support can be used for short-term assistance in selected cases. The work of breathing is always of concern in respiratory cases - muscle fatigue is a problem in chronic cases. Theophylline has been shown to be a positive ionotrrope to the diaphragm (in dogs a 25% increase in diaphragmatic contractility has been reported with plasma theophylline in the "normal" rage) and could be reasonably considered in many cases of chronic respiratory distress.

  3. Normalization of reflexes: Excessive reflexes, which are of concern, include sneezing and reverse sneezing, coughing and airway narrowing reflexes (laryngospasm and bronchospasm). These reflexes are a part of the normal pulmonary defenses and should not be suppressed unless they are excessive and/or debilitating.
    • Coughing is the sudden and often loud ejection of air from the lungs. It is a normal protective reflex, not commonly observed in healthy animals, but necessary in the diseased animal. During a cough, the intrapleural pressure rises dramatically and as a result the intrathoracic airways are compressed. Air is expelled through a narrowed airway and this serves to dislodge irritant materials. Cough is most effective at removing materials from the intrathoracic larger airways, but is not effective in clearing the bronchioles. Coughing is an essential clearance mechanism in lung disease and should not be suppressed unless the cough is dry (non-productive) or physically tiring to the animal, and an attempt has been made to treat a specific cause.
      • Antitussives - Classes of these drugs include:
        • Peripherally acting antitussives include mucosal anesthetics, mucolytics, demulcents, and perhaps bronchodilators.
        • Centrally acting antitussives include both the narcotic and the non-narcotic drugs such as morphine, codeine, hydrocodine, butorphanol and dextromethorphan.
      • Anti-inflammatories - airway inflammation is of concern in many respiratory distress diseases including chronic bronchitis and "feline asthma". Systemic corticosteroids are commonly recommended (e.g. prednisolone), typically starting out at 0.5-1.0mg/kg PO BID and tapering to an EOD schedule. I prefer to use oral prednisolone and educate the owners as to how and when to adjust their pet's requirements (based on the frequency of coughing). Long acting, repositol steroids (DepoMedrol) are effective but should be avoided if possible due to the inability to manage the fluctuating steroid requirements that many of these animals have. We are all familiar with the adverse effect of inducing diabetes mellitus in cats who have received these drugs.
    • Airway narrowing: Both laryngospasm and bronchospasm occur in response to irritation of the epithelial receptors.
      • Laryngospasm - Normally laryngospasm is not a clinical problem unless there is actual laryngeal manipulation or when chronic irritation leads to edema. Topical anesthetics, corticosteroids and "TLC" are the treatments/preventions.
      • Bronchospasm - Bronchodilators are commonly used in the treatment of canine and feline airway disease. Pulmonary function testing is used in human medicine to determine the indication for the use of these agents but these tests are not available in veterinary medicine at this time. The indications for using bronchodilators in dogs and cats are quite subjective, but include historical (chronic cough, wheezing), and physical findings (expiratory effort/abdominal push, crackles, increased tracheal sensitivity) as well as radiographic findings (bronchial pattern, diaphragmatic flattening).
        • Beneficial effects of bronchodilators include bronchodilation, increased mucociliary clearance, improvement in diaphragmatic contractility, decreased pulmonary artery pressure, increased CNS sensitivity to PaCO2 and stabilization of mast cells (depending on drug) to name a few. Although bronchodilation is a proven fact in man (via pulmonary function testing), evidence for drug-induced bronchodilation has been demonstrated in the horse but is sparse in the dog and cat.
    There are three types of bronchodilators that have been used in human and veterinary medicine: (1) the anticholinergics, (2) the beta-adrenergic agonists and (3) the methylxanthines.
    • Anticholinergics have unwarranted side effects that preclude long-term use. Newer anticholinergics, developed for use in human medicine, are available as self-actuated aerosol inhalers.
    • Beta adrenergics (agonists) - terbutaline
      (0.625 mg/cat Q12; 1.25-5 mg/dog Q8-12; and
      albuterol, 25-50 mcg/kg Q8 in dogs) have been
      recommended in treating chronic obstructive
      airway disease. Injectable terbutaline (0.01 mg/kg IV or SQ) may be used for severe bronchoconstriction (e.g. "status asthmaticus").
    • Methylxanthines are a family of drugs that have been used in veterinary medicine for over 80 years, and include theophylline, caffeine and theobromine. Theophylline is considered to have been one of the major drugs for the treatment of asthma and other chronic obstructive pulmonary diseases in man. Theophylline has been used extensively for the treatment of human asthma and other reversible airway diseases.
    Beneficial effects on the respiratory system include bronchodilation (via smooth muscle relaxation), enhanced mucociliary clearance, stimulation of the respiratory center and an increased sensitivity to PaCO2, increased diaphragmatic contractility and stabilization of mast cells. There are species differences in susceptibility to theophylline toxicities, and there may also be a difference within the same species depending on the route of administration (e.g. IV vs. oral) and the duration of therapy (acute vs. chronic).
Potential side effects of methylxanthines (e.g. aminophylline and theophylline) in dogs and cats include tachycardia, restlessness, excitability, vomiting, and diarrhea; side effects are unlikely using proven extended-release oral theophylline products (not generics!). EDTA plasma samples (drawn 4-5 hours in the dog and 10-12 hours in the cat post pilling) may be run to evaluate peak plasma theophylline concentrations. Combination therapy with drugs that inhibit hepatic P450 enzymes (erythromycin, cimetidine and fluoroquinolones) should be used with caution since plasma theophylline concentrations may be significantly altered (increased).

Numerous theophylline (all human) products have been evaluated in dogs and cats, however few have shown suitable pharmacokinetics to be used on a routine clinical basis. Theo-Dur and Slo-bid were 2 such products that were available in the US for human use but unfortunately were discontinued a few years ago. Another company's product has recently been evaluated and is now the only theophylline product available in the US that is proven to have suitable kinetics for canine use (Linwood Labs brand extended-release theophylline capsules and tablets). The dose for the dog is 10mg/kg PO BID (See JAVMA, April 1st, 2004 article).

Newer therapies for the treatment of feline tracheobronchial disease have included serotonin (found to be a mediator of feline airway constriction) receptor inhibition (e.g. cyproheptadine) and the use of cyclosporine in refractory cases (as another method for suppressing airway inflammation) has been shown beneficial in Dr. Padrid's experimental model of feline asthma.

Many human asthmatics are now treated with new drug therapies such as leukotriene receptor blockers, or inhibitors of the enzyme 5-lipoxygenase which is responsible for the formation of leukotrienes themselves. These "human" drugs include Zileuton (Zyflo) an inhibitor of 5-lipoxygenase, montelukast (Singulair) and zafirlukast (Accolate), both leukotriene receptor blockers. Clinical efficacy in people has been demonstrated in a number of large clinical trials. There has been a lot of electronic (the internet) press for using these agents in feline airway disease but (based on 2 separate scientific studies) this class of drugs has not been shown to be efficacious in cats to date.

Recently, there has been considerable discussion about the use of metered dose inhalers (MDIs). Although there are many testimonial cases (mine included!) that attest to the efficacy and success of inhaled steroids and bronchodilators, no detailed peer-reviewed articles have been published to my knowledge. The major point with MDIs is the delivery system. In human medicine considerable time and training is provided patients to ensure the correct delivery of these aerosols. In veterinary medicine we must rely on spacers (as is needed in infants and children) to hold the aerosolized medications while the animal breathes it in. A facemask must be used and we are just learning how to effectively do this. Aerocat, Aerodawg and the new Nebulair line of products are some veterinary systems that are available - there are also numerous pediatric units that may work as well (e.g. the Panda mask and chamber).

DVM Pharmaceuticals has developed a product line (the Nebulair system) specifically for aerosol therapy in small animals, including a feline face mask, an aerosol chamber, a portable ultrasonic nebulizer and a canine aerosol circuit. Research on these new aerosol components is currently underway.

Attention to the animal's environment is an important part of good respiratory therapy. Looking for potential airway irritants can be time consuming but when found very rewarding. Some of the possible triggers of airway irritation that I ask owners about include: smokers in the house, dusty and/or scented cat litter, use of room fresheners or deodorizers, frequency of filter changes on air conditioners and forced air furnaces, recent house changes (moving, remodeling) etc.

Additional Reading:
  • Bach, J. E., Kukanich, B., Papich, M. G., McKiernan, B. C. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs. J Am Vet Med Assoc. 2004;224:1113-9.
  • Brady, C. A. Bacterial pneumonia in dogs and cats. In: King LG ed. Textbook of respiratory disease in dogs and cats. St. Louis: WB Saunders, 2004;412-421.
  • Kuehn, N. F. Chronic bronchitis in dogs. In: King LG ed. Textbook of respiratory disease in dogs and cats. St. Louis: WB Saunders, 2004;379-87.
  • McKiernan, B. C. Diagnosis and treatment of canine chronic bronchitis. Twenty years of experience. VCNA 2000;30:1267-78.
  • McKiernan, B. C. Chronic Bronchitis (COPD). In: Tilley LP and Smith FWK eds., 3rd ed., The 5 Minute Veterinary Consult. Baltimore: Lea & Febier, 2004;174-75.
  • Olsen, J. D. Rational antibiotic therapy for respiratory disorders in dogs and cats. VCNA 2000;30:1337-55.
  • Padrid, P. Feline Asthma. Diagnosis and treatment. VCNA 2000;30:1279-93.
  • Peeters, D. E., McKiernan, B. C., Weisiger, R. M., Schaeffer, D. J. and Clercx, C. Quantitative bacterial cultures and cytological examination of bronchoalveolar lavage specimens in dogs. JVIM 2001;14:534-41.
  • Reiss, A. J. and McKiernan, B. C. Pneumonia. In: Wingfield WE and Raffe MR eds. The Veterinary ICU Book. Jackson Hole: Teton NewMedia, 2002;643-654.



© 2005 - Brendan C. McKiernan, DVM, DACVIM - All rights reserved